000			03062nam a22004215i 4500
999			_c120839 _d120839 _x1
001			120839
003			ES-MaUEC
005			20230102114108.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			200528s2020 gw | s |||| 0|eng d
020			_a9783030246976
024	7		_a10.1007/978-3-030-24697-6 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC262 _b2020 EB
245	0	0	_aRare Sarcomas _cedited by Christine Chevreau, Antoine Italiano.
250			_a1st ed. 2020.
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2020
300			_a1 recurso en línea (V, 164 páginas) _b29 ilustraciones, 24 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF _2rda
490	0		_aMedicine (Springer-11650)
505	0		_aClear cell sarcoma -- Epithelioid sarcoma -- PEComa -- Desmoplastic small round cell tumour -- Malignant solitary fibrous tumour -- Alveolar soft part sarcoma -- Epithelioid Hemangioendothelioma -- Low grade fibromyxoid sarcoma/sclerosing epithelioid fibrosarcoma -- New Born and Infant Soft Tissue Sarcomas.
520	3		_aThis is a unique book focusing on the management of rare sarcomas, which pose an important challenge in Europe and in the US, as they represent nearly one quarter of all new diagnoses of cancer and have lower survival rates than common cancer. Discussing a range of tumors from clear cell and epithelioid sarcoma to solitary fibrous tumor and myxoid fibrosarcoma, this book provides invaluable expertise according to evidence-based guidelines and uses a patient-centered multi-disciplinary approach. Each of the chapters discusses the forms of rare sarcomas both from an oncological and a pathological perspective. This book aims to help the sarcoma expert in improving the management, quality of care and outcome for patients with rare tumors, which have now been recognised as a public health priority. The authors are experts from specialist sarcoma centers focusing on the capacity to develop clinical guidelines, and to foster clinical, translational and epidemiological research for rare cancers.
988			_aSpringer_Medicine_2020
650		7	_2embne _9675149 _aSarcoma
700	1		_aChevreau, Christine. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _1http://viaf.org/viaf/29712199
700	1		_aItaliano, Antoine. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729
776	0	8	_iPrinted edition: _z9783030246969
776	0	8	_iPrinted edition: _z9783030246983
776	0	8	_iPrinted edition: _z9783030246990
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-24697-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b09/2020 _dz _eIG _zSI